Doc, while I agree with you, I actually think that LP's goals go well beyond the existing DCVax's. I don't know that she'll keep the company independent, but the way she's adding other technologies to what originally was represented by the DCVax's alone is an indication that she wants to take this into many new therapeutics, largely dendritic cell based, but she's looking to make this a giant in the field.
Gary
Bullish
Market Data 
Markets 
AI
